| 摘要 |
<p>The inventive medicinal agent is based on antibodies and contains an activated form of ultra low doses of monoclonal, polyclonal or natural anti-granulocyte and anti-colony-stimulating factor antibodies which are produced by a repetitive successive dilution and an external action being used mainly by means of homeopathic technology. In order to produce said antibodies, a human or heterologous granulocyte colony-stimulating factor including recombinant or genetic engineering factors are used, whereby a mixture of different, centesimal homeopathic dilutions mainly used. The inventive method for curing pathologic syndrome associated to hemodyscrasia, mainly granulopoiesis consists in using activated forms of ultra low doses of anti-granulocyte and anti-colony-stimulating factor antibodies which are produced by a repetitive successive dilution and an external action.</p> |
